Edesa Biotech, Inc. · NASDAQ:EDSA
Velan Capital Investment Management LP reported a 9.99% stake in Edesa Biotech, Inc. (Schedule 13D/A)
Event Aug 21, 2026 · Filed Aug 25, 2026
Velan Capital Investment Management LP reported a 9.99% stake in Edesa Biotech, Inc., 1,356,455 shares, with active intent on Aug 21, 2026. Filed Aug 25, 2026 (Schedule 13D/A).
- Stake
- 9.99%
- Shares
- 1,356,455
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Velan Capital Master Fund LP | 8.00% | 1,081,385 |
| Velan Horizon Fund LP | 0.20% | 25,070 |
| Velan Capital Opportunity Fund II LLC | 1.90% | 250,000 |
| Velan Horizon GP LLC | 0.20% | 25,070 |
| Velan Capital Holdings LLC | 9.80% | 1,331,385 |
| Velan Capital Investment Management LP | 9.99% | 1,356,455 |
| Velan Capital Management LLC | 9.99% | 1,356,455 |
| Morgan Adam | 9.99% | 1,356,455 |
| VENKATARAMAN BALAJI | 9.99% | 1,356,455 |
Source
Related
- Edesa Biotech, Inc.
- Velan Capital Investment Management LP
- Edesa Biotech, Inc. shareholders
- Schedule 13D/A · Velan Capital Investment Management LP · Mar 2, 2026
- Schedule 13D · Velan Capital Investment Management LP · Feb 18, 2025
- Form 4 · Nijhawan Pardeep · Oct 6, 2026
- Form 4 · Nijhawan Pardeep · Sep 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Aug 26, 2026
- Schedule 13D/A · Nijhawan Pardeep · Aug 25, 2026
- Form 4 · Nijhawan Pardeep · Aug 4, 2026